Role of Homoeopathic medicines in the treatment of attention deficit hyperactivity disorder
Not Applicable
- Conditions
- Health Condition 1: F90- Attention-deficit hyperactivity disorders
- Registration Number
- CTRI/2023/02/049976
- Lead Sponsor
- Bakson Homoeopathic Medical College and Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Children & adolescents diagnosed with attention deficit hyperactivity disorder.
2. Age group 6 -18 years.
3. Both genders.
4. Children & adolescents suffering from ADHD with co-morbidities (ASD, CD, ODD, LD).
5. Undergoing Behaviour Therapy.
Exclusion Criteria
1. Children & adolescents who are on psychotropic drugs & allopathic medicines for ADHD.
2. History of Drug Abuse, Epilepsy, and Chronic neurological disorder.
3. Children & adolescents with other severe systemic illnesses.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in SNAP-IV (Swanson, Nolan and Pelham) 26-Item Teacher and Parent Rating Scale is expected to show an improvement in patients of Attention Deficit Hyperactivity DisorderTimepoint: SNAP-IV (Swanson, Nolan and <br/ ><br>Pelham) 26-Item Teacher and Parent Rating Scale will be used at baseline, 4 weeks, 8 weeks, 12 weeks, 16 weeks, 20 weeks, 24 weeks. <br/ ><br>15 months study <br/ ><br>6 months enrolment <br/ ><br>6 months follow up <br/ ><br>3 months evaluation
- Secondary Outcome Measures
Name Time Method OT APPLICABLETimepoint: NI